← SynDRA
METRIZAMIDE
SynDRA canonical compound SYN0011702 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Mechanism of action | radiopaque medium |
|---|
| Indication | contrast agent |
|---|
| Disease area | radiology |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- HTR2A
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MAOB
- MC3R
- MC4R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SAMHD1
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HTR2B
- HTR1A
- ADORA2A
- HRH2
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
- BDKRB2
Drug classes
- Contrast Media
- Diagnostic Uses of Chemicals
- radiopaque medium
ATC classes
- V08A · X-RAY CONTRAST MEDIA, IODINATED
Cross-references
Synonyms
- AMIPAQUE
- amipaque
- telebrix
- Metrizamida
- Telebrix 300
- WIN-39103
- Amipaque
- DTXCID203310
- WIN 39103
- RefChem:58590
- V08AB01
- Metrizamidum
- RHH3W8F1CO
- BAQCROVBDNBEEB-UBYUBLNFSA-N
- NCGC00016805-01
- Amipaque (TN)
- CAS-31112-62-6
- Prestwick3_000463
- SCHEMBL24382
- BSPBio_000566
- MLS002153823
- Metrizamide (JAN/USAN/INN)
- BPBio1_000624
- orb1696113
- SCHEMBL16984723
- CHEBI:31841
- HMS2096M08
- HMS2230M07
- HMS3713M08
- Tox21_110619
- STL564457
- AKOS015965061
- CCG-220463
- CS-W000133
- HY-W000133
- MM01350
- NCGC00179520-01
- NCGC00179520-04
Look up METRIZAMIDE in the interactive SynDRA portal →